BTI
PDSB icon

Blue Trust Inc’s PDS Biotechnology PDSB Stock Holding History

Blue Trust Inc’s Portfolio PDSB Stock Details PDSB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-4,500
Closed -$5.99K – 2653
2025
Q2 		$5.99K Hold
4,500
– – ﹤0.01% 1968
2025
Q1 		$5.36K Hold
4,500
– – ﹤0.01% 2093
2024
Q4 		$7.33K Hold
4,500
– – ﹤0.01% 2017
2024
Q3 		$13.2K Buy
+4,500
New +$15K ﹤0.01% 2099

Other funds holding PDSB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IWA
Inspirion Wealth Advisors Libertyville, Illinois $874M AUM 16.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Blue Trust Inc's PDSB Position: Q3 2025 in Review

Blue Trust Inc sold out of PDS Biotechnology (PDSB) in Q3 2025, closing a stake of 4,500 shares — an estimated $5.99K sold.

Blue Trust Inc first reported a position in PDSB in Q3 2024 and held it in 4 quarters. The position peaked at $13.2K in Q3 2024. 47 funds tracked by Wall St. Rank hold PDSB as of Q3 2025.

  • Blue Trust Inc reported no remaining PDS Biotechnology position as of Q3 2025 after selling out during the quarter.
  • Blue Trust Inc sold 4,500 PDS Biotechnology shares in Q3 2025, an estimated $5.99K.
  • Blue Trust Inc first reported a position in PDS Biotechnology in Q3 2024 and held it in 4 quarters.
  • Blue Trust Inc's PDS Biotechnology position peaked at $13.2K in Q3 2024.
  • 47 funds tracked by Wall St. Rank held PDS Biotechnology as of Q3 2025.

Based on Blue Trust Inc's 13F filing for Q3 2025, filed 16 Oct 2025.